Supply and Manufacture of Investigational Medicinal Products (IMPs) for the Clinical Trial: "Examining Antibiotics for Ulcerated Skin Cancer Surgical Excision"
Cardiff and Vale University Health Board (CAVUHB) is undertaking a clinical trial entitled ‘Examining Antibiotics for Ulcerated Skin Cancer Surgical Excision’, funded by the National Institute for Health and Care Research (NIHR) Health Technology Assessment Programme (Ref: NIHR 160872). As part of this clinical trial, an Investigational Medicinal Product (IMP) needs to be manufactured and distributed.
Buyer
NHS Wales Shared Services Partnership (NWSSP) - Procurement Services
Value
£116,645
Published
20 Jan 2025
Closes
20 Jan 2025
Procurement details
Source
Sell2Wales
Region
United Kingdom
Procurement method
Limited
Category
Goods
Contract starts
Not provided
Contract ends
Not provided
CPV classifications
33000000
Medical equipments, pharmaceuticals and personal care products
Lots
Lot 1 Supply and Manufacture of Investigational Medicinal Products (IMPs) for the Clinical Trial: "Examining Antibiotics for Ulcerated Skin Cancer Surgical Excision"
£116,645
Supply and Manufacture of Investigational Medicinal Products (IMPs) for the Clinical Trial: "Examining Antibiotics for Ulcerated Skin Cancer Surgical Excision" Cardiff and Vale University Health Board (CAVUHB) is undertaking a clinical trial entitled ‘Examining Antibiotics for Ulcerated Skin Cancer Surgical Excision’, funded by the National Institute for Hea...
Delivery: Cardiff and Vale of Glamorgan
Documents
Unlock document linkSupply and Manufacture of Investigational Medicinal Products (IMPs) for the Clinical Trial: "Examining Antibiotics for Ulcerated Skin Cancer Surgical Excision"
Not provided
Cardiff and Vale University Health Board (CAVUHB) is undertaking a clinical trial entitled ‘Examining Antibiotics for Ulcerated Skin Cancer Surgical Excision’, funded by the National Institute for Health and Care Research (NIHR) Health Tech...
Award notice · Web page
Contains public sector information licensed under the Open Government Licence v3.0.